Literature DB >> 11752233

Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1.

S Lautraite1, A C Musonda, J Doehmer, G O Edwards, J K Chipman.   

Abstract

The effects of the flavonoids quercetin, apigenin and chrysin (10 microM) on the genetic toxicity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and benzo[a]pyrene (BaP) was investigated at sub-cytotoxic concentrations in Chinese hamster V79 cells expressing human or rat cytochromes P450. In V79 r1A2-NH and V79 h1A1-MZ cells, none of the flavonoids increased DNA strand breaks (SB) (measured by the Comet assay) or produced detectable DNA adducts (measured by 32P-post-labelling). Neither IQ nor BaP produced DNA damage in the absence of expressed CYP1A2 or CYP1A1, respectively. DNA damage measured as SB and DNA adducts was detectable in V79 r1A2-NH cells expressing rat CYP1A2 when treated with IQ (2.5-50 microM) and this was inhibited by quercetin. Likewise, DNA damage (SB and DNA adducts) was elevated in V79 h1A1-MZ cells expressing human CYP1A1 when treated with BaP (0.1-0.5 microM) and this was inhibited by chrysin and apigenin, but not by quercetin. The specificity of CYP1A1 inhibition by chrysin and apigenin and CYP1A2 inhibition by quercetin was confirmed by ethylresorufin O-deethylase assay.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752233     DOI: 10.1093/mutage/17.1.45

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  12 in total

Review 1.  Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives.

Authors:  Harald P Hoensch; Wilhelm Kirch
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  Effect of Dietary Doses of Quercetin on Hepatic Drug Metabolizing Enzymes in Spontaneously Hypertensive Rats.

Authors:  Fawzy Elbarbry; Aimy Ung; Deepa Rao; Khaled Abdelkawy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

Review 3.  Molecular mechanisms of action of quercetin in cancer: recent advances.

Authors:  Dharambir Kashyap; Sonam Mittal; Katrin Sak; Paavan Singhal; Hardeep Singh Tuli
Journal:  Tumour Biol       Date:  2016-07-22

4.  Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.

Authors:  Agnes A Walsh; Grazyna D Szklarz; Emily E Scott
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

5.  Inhibition of Human Cytochrome P450 Enzymes by Allergen Removed Rhus verniciflua Stoke Standardized Extract and Constituents.

Authors:  Hyunsik Jung; Sanghun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

6.  Liposomal Delivery of Mycophenolic Acid With Quercetin for Improved Breast Cancer Therapy in SD Rats.

Authors:  Gopal Patel; Neeraj Singh Thakur; Varun Kushwah; Mahesh D Patil; Shivraj Hariram Nile; Sanyog Jain; Uttam Chand Banerjee; Guoyin Kai
Journal:  Front Bioeng Biotechnol       Date:  2020-06-16

7.  De novo biosynthesis of myricetin, kaempferol and quercetin in Streptomyces albus and Streptomyces coelicolor.

Authors:  Laura Marín; Ignacio Gutiérrez-Del-Río; Rodrigo Entrialgo-Cadierno; Claudio J Villar; Felipe Lombó
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

8.  Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation.

Authors:  Luigi Capoferri; Marlies C A Verkade-Vreeker; Danny Buitenhuis; Jan N M Commandeur; Manuel Pastor; Nico P E Vermeulen; Daan P Geerke
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

9.  Role of the CYP1A2 Gene Polymorphism on Early Ageing from Occupational Exposure.

Authors:  Sa Eshkoor; P Ismail; Sa Rahman; S Moin; My Adon
Journal:  Balkan J Med Genet       Date:  2013-12       Impact factor: 0.519

10.  Variable inhibitory effect of herbal supplements of different brands on human P450 CYP1A2.

Authors:  Sompon Wanwimolruk; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2012-02-02       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.